CVST With AZ COVID Vaccine: 1 in 40,000 ‘More Reliable’ Estimate
A new study that systematically monitored rates of vascular and thromboembolic events in people receiving the AstraZeneca COVID-19 vaccine has found it to be associated with a rate of cerebral venous sinus thrombosis (CVST) of 1 in 40,000. Using national health records, the researchers identified rates of arterial and venous […]